E-LIB Suche - Ergebnisse für: Suzaki, Yuki

1

Preliminary Investigation of a Rapid and Feasible Therapeut..:

Kato, Masaru ; Maruyama, Shinichi ; Watanabe, Noriko...
The AAPS Journal. 26 (2024) 3 - p. , 2024

Link: https://doi.org/10.1208/..

2

Discrepancy Between Fasting Flow-Mediated Dilation and Para..:

Teramoto, Tamio ; Shibata, Hirotaka ; Suzaki, Yuki...
Advances in Therapy. 37 (2020) 5 - p. 2169-2183 , 2020

Link: https://doi.org/10.1007/..

3

Evaluation of Bioequivalence Between the New Procaterol Hyd..:

Shirai, Ryo ; Suzaki, Yuki ; Sato, Kyoko...
Clinical Pharmacology in Drug Development. 7 (2017) 4 - p. 392-399 , 2017

Link: https://doi.org/10.1002/..

4

Effect of Trelagliptin on Quality of Life in Patients with ..:

Ishii, Hitoshi ; Suzaki, Yuki ; Miyata, Yuko
Diabetes Therapy. 8 (2017) 6 - p. 1415-1425 , 2017

Link: https://doi.org/10.1007/..

5

An Assessment of the Oral Bioavailability of Three Ca-Chann..:

Yamashita, Shinji ; Kataoka, Makoto ; Suzaki, Yuki...
Journal of Pharmaceutical Sciences. 104 (2015) 9 - p. 3154-3161 , 2015

Link: https://doi.org/10.1002/..

6

Gly143Glu polymorphism of the human carboxylesterase1 gene ..:

Suzaki, Yuki ; Uemura, Naoto ; Hosokawa, Masakiyo.
European Journal of Clinical Pharmacology. 69 (2012) 3 - p. 735-736 , 2012

Link: https://doi.org/10.1007/..

7

The effect of carboxylesterase 1 (CES1) polymorphisms on th..:

Suzaki, Yuki ; Uemura, Naoto ; Takada, Makoto...
European Journal of Clinical Pharmacology. 69 (2012) 1 - p. 21-30 , 2012

Link: https://doi.org/10.1007/..

8

SEQUENTIAL ACTIVATION OF THE REACTIVE OXYGEN SPECIES/ANGIOT..:

Miyata, Kayoko ; Ohashi, Naro ; Suzaki, Yuki..
Clinical and Experimental Pharmacology and Physiology. 35 (2008) 8 - p. 922-927 , 2008

Link: https://doi.org/10.1111/..

9

Enhanced intrarenal oxidative stress and angiotensinogen in..:

Kobori, Hiroyuki ; Katsurada, Akemi ; Ozawa, Yuri...
Biochemical and Biophysical Research Communications. 358 (2007) 1 - p. 156-163 , 2007

Link: https://doi.org/10.1016/..

10

Intrarenal Oxidative Stress and Augmented Angiotensinogen a..:

Suzaki, Yuki ; Ozawa, Yuri ; Kobori, Hiroyuki
International Journal of Biological Sciences. , 2007

Link: https://doi.org/10.7150/..

11

Quantification of human angiotensinogen by a novel sandwich..:

Suzaki, Yuki ; Ozawa, Yuri ; Kobori, Hiroyuki
Peptides. 27 (2006) 11 - p. 3000-3002 , 2006

Link: https://doi.org/10.1016/..

12

Androgen Receptor Gene Knockout Male Mice Exhibit Impaired ..:

Ikeda, Yasumasa ; Aihara, Ken-ichi ; Sato, Takashi...
Journal of Biological Chemistry. 280 (2005) 33 - p. 29661-29666 , 2005

Link: https://doi.org/10.1074/..

13

Ebselen inhibits tumor necrosis factor-α-induced c-Jun N-te..:

Yoshizumi, Masanori ; Fujita, Yoshiko ; Izawa, Yuki...
Experimental Cell Research. 292 (2004) 1 - p. 1-10 , 2004

Link: https://doi.org/10.1016/..

14

Ebselen attenuates oxidative stress‐induced apoptosis via t..:

Yoshizumi, Masanori ; Kogame, Toshiaki ; Suzaki, Yuki...
British Journal of Pharmacology. 136 (2002) 7 - p. 1023-1032 , 2002

Link: https://doi.org/10.1038/..

15

Quercetin glucuronide prevents VSMC hypertrophy by angioten..:

Yoshizumi, Masanori ; Tsuchiya, Koichiro ; Suzaki, Yuki...
Biochemical and Biophysical Research Communications. 293 (2002) 5 - p. 1458-1465 , 2002

Link: https://doi.org/10.1016/..